New Treatment Stops Anthrax Toxin in Rats

Using an animal model, scientists have discovered a way to inactivate the lethal toxin produced by the anthrax bacterium.

The findings provide a potential route to therapy of anthrax that could complement antibiotics.

Anthrax infection -- lately in the news because of its potential for use as a biological weapon -- can be contracted by humans through the skin or by inhalation.

Antibiotics can treat the infection, but they must be given quickly. And while they may kill the anthrax bacterium, they cannot inactivate the lethal toxin it produces.

By the time symptoms of anthrax contracted by inhalation have appeared, it is generally too late to rescue an individual with antibiotics, because he or she will succumb to the toxin the bacteria has already produced.

Anthrax releases three nontoxic proteins that assemble themselves into the toxin. Investigators have identified a protein, known as a polyvalent inhibitor, that blocks this assembly.

The researchers have tested the polyvalent inhibitor of toxin action by mixing it with a potentially lethal dose of the lethal toxin and injecting the mixture into rats.

Normally, the lethal dose of toxin will kill the animal within 90 minutes. In the presence of the polyvalent inhibitor, the animals survived and showed no symptoms.

This finding supports the notion that this inhibitor could be used to block toxin action in infected humans and rescue them. According to the researcher, inhalation anthrax is the most deadly form of the disease. It is contracted by inhaling anthrax spores -- durable, hard-shelled "seeds" containing the bacterium.

The spores begin to grow in the lungs and enter the bloodstream, where they produce the anthrax toxin. The toxin acts by killing certain immune system cells that normally guard against bacterial invaders. In so doing it also causes changes in metabolism that lead to death.

Nature Biotechnology October 2001;19:958-961

DR. MERCOLA'S COMMENT:

This is certainly an exciting development that would be a welcome addition to the limited arsenal we have to protect against the bioterrorism germ warfare threat.

Related Articles:

Anthrax index

Return to Table of Contents #263

©Copyright 1997-2001 by Joseph M. Mercola, DO. All Rights Reserved. This content may be copied in full, with copyright; contact; creation; and information intact, without specific permission, when used only in a not-for-profit format. If any other use is desired, permission in writing from Dr. Mercola is required.

Disclaimer - Newsletters are based upon the opinions of Dr. Mercola. They are not intended to replace a one-on-one relationship with a qualified health care professional and they are not intended as medical advice. They are intended as a sharing of knowledge and information from the research and experience of Dr. Mercola and his community. Dr. Mercola encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional.